When.com Web Search

  1. Ads

    related to: does alendronate increase bone density after 70

Search results

  1. Results From The WOW.Com Content Network
  2. Alendronic acid - Wikipedia

    en.wikipedia.org/wiki/Alendronic_acid

    Alendronic acid, sold under the brand name Fosamax among others, is a bisphosphonate medication used to treat osteoporosis and Paget's disease of bone. [4] It is taken by mouth. [ 4 ] Use is often recommended together with vitamin D , calcium supplementation , and lifestyle changes.

  3. Bisphosphonate - Wikipedia

    en.wikipedia.org/wiki/Bisphosphonate

    Long-term treatment with bisphosphonates produces anti-fracture and bone mineral density effects that persist for 3–5 years after an initial 3–5 years of treatment. [2] The bisphosphonate alendronate reduces the risk of hip, vertebral, and wrist fractures by 35-39%; zoledronate reduces the risk of hip fractures by 38% and of vertebral ...

  4. Alendronic acid/colecalciferol - Wikipedia

    en.wikipedia.org/wiki/Alendronic_acid/colecalciferol

    Alendronic acid/colecalciferol, sold under the brand name Fosamax Plus D among others, is a medication for the treatment of osteoporosis in men or in postmenopausal women. [ 3 ] [ 2 ] [ 4 ] [ 6 ] Alendronic acid/colecalciferol was approved for use in the United States and in the European Union in 2005.

  5. This Is the #1 Sign of Healthy Bones, According to ... - AOL

    www.aol.com/lifestyle/1-sign-healthy-bones...

    For premium support please call: 800-290-4726 more ways to reach us

  6. Senile osteoporosis - Wikipedia

    en.wikipedia.org/wiki/Senile_osteoporosis

    [19] [20] Given bone fracture (hip, vertebrae, and colles) is a devastating complication of osteoporosis, vitamin D3 combined with calcium are used as primary prevention, along with alendronate, residronate, strontium and zoledronic acid which have proven efficacy in primary and secondary hip fracture prevention. [21]

  7. Osteoporosis - Wikipedia

    en.wikipedia.org/wiki/Osteoporosis

    Osteoporosis is a systemic skeletal disorder characterized by low bone mass, micro-architectural deterioration of bone tissue leading to more porous bone, and consequent increase in fracture risk. It is the most common reason for a broken bone among the elderly . [ 3 ]